Neogen Corporation (NEOG)
| Market Cap | 2.58B +107.6% |
| Revenue (ttm) | 870.40M -2.7% |
| Net Income | -7.90M |
| EPS | -0.04 |
| Shares Out | 218.06M |
| PE Ratio | n/a |
| Forward PE | 38.16 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,263,001 |
| Open | 11.47 |
| Previous Close | 11.64 |
| Day's Range | 11.37 - 11.85 |
| 52-Week Range | 4.90 - 12.85 |
| Beta | 1.76 |
| Analysts | Buy |
| Price Target | 13.33 (+12.68%) |
| Earnings Date | Oct 8, 2026 |
About NEOG
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns fo... [Read more]
Financial Performance
In fiscal year 2026, Neogen's revenue was $870.40 million, a decrease of -2.72% compared to the previous year's $894.70 million. Losses were -$7.90 million, -99.28% less than in 2025.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price target is $13.33, which is an increase of 12.68% from the latest price.
News
Neogen upgraded to Overweight from Neutral at Piper Sandler
Piper Sandler upgraded Neogen (NEOG) to Overweight from Neutral with a price target of $14, up from $13. The company has posted several consecutive quarters of improving performance, with food…
Neogen Proxy statement: Proxy filing
Neogen filed a proxy statement on August 21, 2026, providing details for shareholder voting and corporate governance matters.
Neogen Proxy statement: Proxy filing
Neogen filed a proxy statement on August 21, 2026, providing details for shareholder voting and corporate governance matters.
Sera CFO Austin Aerts to transition out of role, Scott Gleason to succeed
Sera Prognostics (SERA) announced that Scott Gleason has been appointed CFO, effective August 31. Most recently, he served as VP of investor relations and treasury at Neogen Corporation (NEOG). Austin...
Neogen price target raised to $13 from $11 at Piper Sandler
Piper Sandler raised the firm’s price target on Neogen (NEOG) to $13 from $11 and keeps a Neutral rating on the shares. The firm cites commentary around a better animal…
Neogen Earnings Call Transcript: Q4 2026
Q4 saw strong core growth in both food and animal safety, with food safety up 5.8% and gross margin improving 330 bps year-over-year. FY27 guidance targets $880–$885M revenue and 20.5% EBITDA margin, with major investments in R&D and operational efficiency planned.
Neogen Earnings release: Q4 2026
Neogen released its Q4 2026 earnings on July 30, 2026, summarizing the period's financial results.
Neogen Slides: Q4 2026
Neogen has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on July 30, 2026.
Neogen Annual report: Q4 2026
Neogen has published its Q4 2026 annual report on July 30, 2026.
Neogen reports Q4 adjusted EPS 9c, consensus 6c
Reports Q4 revenue $225.3M, consensus $212.35M. “We ended fiscal year 2026 with significant momentum and have a number of initiatives underway to further enhance our commercial efforts and the way…
Neogen sees FY27 revenue $880M-$885M, consensus $849.08M
Sees FY27 adjusted EBITDA $180M-$182M
Neogen sees Q1 revenue $207M-$209M, consensus $204.7M
Sees Q1 adjusted EBITDA $37M
Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fiscal year 2...
Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on July 30, 2026
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Thursday, July 30, 2026. Executives from the comp...
Neogen announces expanded availability of FIFRA recommendations for Prozap use
Neogen (NEOG) Corporation announced the expanded availability of FIFRA Section 2(ee) recommendations for the use of Prozap Insectrin X Concentrate and Prozap Screw Worm and Ear Tick Aerosol as part…
Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommen...
Neogen’s Listeria Right Now test receives AOAC PTM certification
Neogen (NEOG) announced that its Molecular Detection Assay – Listeria Right Now rapid environmental monitoring test has received AOAC Performance Tested Methods certification, validating the test’s pe...
Neogen's Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that its Molecular Detection Assay - Listeria Right Now™ rapid envir...
Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren't Helping.
Neogen's animal safety business is a drag on earnings in the face of ‘third-party' setbacks.
Neogen Earnings Call Transcript: Q3 2026
Core food safety growth remained strong, with adjusted EBITDA margin at 22.8% and revenue guidance raised to $857–$860 million. Animal safety faced supply chain headwinds, but operational and innovation initiatives are underway to drive future margin and cash flow improvements.
Neogen Quarterly report: Q3 2026
Neogen has published its Q3 2026 quarterly earnings report on April 9, 2026.
Neogen Earnings release: Q3 2026
Neogen released its Q3 2026 earnings on April 9, 2026, summarizing the period's financial results.
Neogen Slides: Q3 2026
Neogen has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on April 9, 2026.
Neogen reports Q3 adjusted EPS 9c, consensus 5c
Reports Q3 revenue $211.2M, consensus $204.62M. “We continued to make significant progress on our strategic transformation in the third quarter as we look to stabilize and strengthen our core business...
Neogen raises FY26 revenue view to $857M-$860M from $845M-$855M
Consensus $850.87M.